SOURCE: Medrio Inc.

Medrio Logo

April 12, 2016 09:00 ET

Medrio's 2016 mSquared User Conference Wraps Up in San Francisco

SAN FRANCISCO, CA--(Marketwired - April 12, 2016) - Medrio, a Software as a Service (SaaS) company providing eClinical technology for clinical trials, held its annual mSquared user conference on March 21st, 22nd, and 23rd at the Loews Hotel in San Francisco's Financial District. In attendance were Medrio staff and customers. The conference consisted of three days of presentations, panel discussions, and events. Customers also had the opportunity to schedule one-on-one information sessions with members of Medrio staff. Major items and topics of discussion in this year's conference included:

  • mSource, a suite of new Medrio products equipped with eSource technology, including mPRO, mCapture, and mConsent.
  • Release 35, a rollout of features due for release early in the second quarter of this year.
  • Dubbed "Medrio Rocks," the event was underscored by a rock & roll theme.

Medrio holds mSquared every year to ensure customers have the opportunity to engage directly with Medrio staff on a regular basis. "It's very important for us to be able to interface with our customers," said Scott Weidley, Vice President of Sales, Marketing and Customer Success at Medrio. "We want our users to be able to offer their feedback about our products, learn firsthand about our upcoming features, and get to know us as people. mSquared enables them to do that, and we think this year's conference was one of our best."

About Medrio

Medrio offers an integrated eClinical software platform with a fully hosted EDC system. Our revolutionary CloudEDC™ technology features an easy to use drag-and-drop interface, allowing study managers to build their studies in days instead of months without requiring any programming. Medrio's new mobile eSource suite, mSource, supports both event-based and subject-based workflows, offline data entry, and Patient Reported Outcomes (PRO). Although Medrio has extensive experience in all study phases, with over 500 Phase I trials to date, our m1 application leads the way in early phase and Phase I trials. Medrio costs up to 75% less than traditional EDC solutions. To schedule a demo, please submit your information here and a member of our team will be in touch shortly.

Contact Information